Thomas Martin Selected Research

Thomas Martin Research Topics

Disease

50	Multiple Myeloma 03/2024 - 03/2006
14	Neoplasms (Cancer) 06/2023 - 04/2002
7	Residual Neoplasm 03/2024 - 01/2019
7	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 04/2004
5	Disease Progression 03/2024 - 05/2012
4	Infections 12/2023 - 02/2022
4	Obstructive Sleep Apnea 02/2014 - 01/2011
3	Neutropenia 12/2022 - 07/2007
3	Chronic Obstructive Pulmonary Disease (COPD) 02/2019 - 04/2002
3	Hypoxia (Hypoxemia) 08/2013 - 01/2011
2	Cytokine Release Syndrome 12/2023 - 01/2023
2	cell-associated neurotoxicity 12/2023 - 01/2023
2	Amyloidosis 01/2023 - 10/2022
2	Body Weight (Weight, Body) 11/2022 - 04/2002
2	Infarction (Infarctions) 01/2020 - 09/2011
2	Hyperoxia 01/2018 - 04/2012
2	Inflammation (Inflammations) 12/2015 - 01/2013
1	Chromosome Aberrations (Chromosome Abnormalities) 03/2024
1	Brain Death (Brain Dead) 01/2024
1	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2023
1	Hemorrhage 11/2023
1	COVID-19 05/2023
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023
1	Delirium 01/2023
1	Agammaglobulinemia (Hypogammaglobulinemia) 01/2023
1	Cytopenia 01/2023
1	Lymphopenia (Lymphocytopenia) 12/2022
1	Plasmacytoma 11/2022
1	Thromboembolism 01/2022
1	Frailty 09/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 09/2021
1	Gingivitis 06/2021
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021

Drug/Important Bio-Agent (IBA)

18	isatuximabIBA 03/2024 - 01/2017
16	carfilzomibIBA 03/2024 - 10/2012
15	Dexamethasone (Maxidex)FDA LinkGeneric 03/2024 - 01/2017
12	Chimeric Antigen ReceptorsIBA 03/2024 - 01/2021
10	B-Cell Maturation AntigenIBA 03/2024 - 01/2021
9	Proteasome InhibitorsIBA 01/2023 - 10/2012
9	Monoclonal AntibodiesIBA 11/2022 - 01/2017
8	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 03/2024 - 01/2021
5	Proteins (Proteins, Gene)FDA Link 06/2023 - 10/2003
5	Lenalidomide (CC 5013)FDA Link 01/2022 - 05/2012
4	VaccinesIBA 12/2023 - 10/2003
4	LeptinIBA 02/2014 - 01/2011
3	Messenger RNA (mRNA)IBA 05/2023 - 01/2003
3	Immunoglobulins (Immunoglobulin)IBA 02/2022 - 08/2013
2	Bispecific AntibodiesIBA 12/2023 - 01/2023
2	Heparin (Liquaemin)FDA LinkGeneric 11/2023 - 01/2020
2	AntigensIBA 05/2023 - 09/2004
2	Immunoglobulin G (IgG)IBA 01/2023 - 10/2003
2	Immunoconjugates (Immunoconjugate)IBA 01/2023 - 11/2015
2	Immunomodulating AgentsIBA 01/2023 - 01/2022
2	Single-Domain AntibodiesIBA 12/2022 - 01/2021
2	pomalidomideIBA 11/2022 - 01/2021
2	daratumumabIBA 11/2022 - 10/2022
2	antineoplaston A10 (A 10)IBA 01/2022 - 03/2019
2	Etoposide (VP 16)FDA LinkGeneric 01/2021 - 03/2006
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2021 - 01/2019
2	Proteasome Endopeptidase Complex (Proteasome)IBA 12/2020 - 01/2019
2	Oxygen (Dioxygen)IBA 02/2019 - 12/2018
2	Interleukin-6 (Interleukin 6)IBA 02/2019 - 11/2003
2	PanobinostatIBA 01/2019 - 01/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2013 - 03/2013
2	Tissue Kallikreins (Tissue Kallikrein)IBA 09/2004 - 01/2003
1	Adenosine Monophosphate (AMP)IBA 03/2024
1	Intravenous Immunoglobulins (IVIG)FDA Link 12/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2023
1	Enoxaparin (Lovenox)FDA LinkGeneric 11/2023
1	2019-nCoV Vaccine mRNA-1273IBA 05/2023
1	BNT162 VaccineIBA 05/2023
1	COVID-19 VaccinesIBA 05/2023
1	Recombinant ProteinsIBA 05/2023
1	N-(2-cyanoethylene)urea (BA 1)IBA 05/2023
1	Combined VaccinesIBA 05/2023
1	Amyloid (Amyloid Fibrils)IBA 01/2023
1	Dihydrotachysterol (AT 10)IBA 01/2023
1	lysine(6)- glutaryl- 2- (hydroxymethyl)anthraquinone LHRH (T 98)IBA 12/2022
1	Thalidomide (Thalomid)FDA Link 01/2022
1	Indicators and Reagents (Reagents)IBA 09/2021
1	Ointments (Pastes)IBA 06/2021
1	carboxyl radical (COO-)IBA 01/2021
1	ofatumumab FDA Link 01/2021

Therapy/Procedure

35	Therapeutics 03/2024 - 10/2003
7	Drug Therapy (Chemotherapy) 06/2023 - 01/2006
6	Radiotherapy 01/2021 - 10/2002
5	Brachytherapy 03/2013 - 07/2003
3	Stem Cell Transplantation 01/2021 - 05/2012
2	Transplantation 01/2024 - 10/2003
2	Aftercare (After-Treatment) 06/2023 - 05/2003
2	Nephrectomy 09/2021 - 10/2020
2	Catheters 12/2020 - 07/2003
2	Injections 12/2015 - 06/2004
2	Hematopoietic Stem Cell Transplantation 05/2012 - 10/2003
1	Salvage Therapy 03/2024
1	Retreatment 03/2024
1	Blood Component Removal (Apheresis) 12/2023
1	Subcutaneous Injections 11/2022
1	Cell Transplantation 01/2021